Back
Verrica Pharmaceuticals Stock Price Chart
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
25
VRCA
Verrica Pharmaceuticals
Last Price:
0.87
Seasonality Move:
34.27%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's IRS Hands Massive 'Victory Gift' To 401K Owners
Shield your IRA, 401(k) and pension savings from this coming anti-Trump backlash.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VRCA is experiencing selling pressure, which indicates risk of future bearish movement.
Verrica Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.91 | Sell |
| 20-day SMA: | 1.29 | Sell |
| 50-day SMA: | 1.51 | Sell |
| 200-day SMA: | 5.17 | Sell |
| 8-day EMA: | 0.97 | Sell |
| 20-day EMA: | 1.19 | Sell |
| 50-day EMA: | 1.85 | Sell |
| 200-day EMA: | 4.21 | Sell |
Verrica Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.23 | Sell |
| Relative Strength Index (14 RSI): | 34.29 | Sell |
| Chaikin Money Flow: | -243328 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.99 - 1.61) | Sell |
| Bollinger Bands (100): | (1.02 - 6.26) | Sell |
Verrica Pharmaceuticals Technical Analysis
| Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Verrica Pharmaceuticals Stock
Is Verrica Pharmaceuticals Stock a Buy?
- Verrica Pharmaceuticals share price is 0.84 while VRCA 8-day simple moving average is 0.91, which is a Sell signal.
- The stock price of VRCA is 0.84 while Verrica Pharmaceuticals 20-day SMA is 1.29, which makes it a Sell.
- Verrica Pharmaceuticals 50-day simple moving average is 1.51 while VRCA share price is 0.84, making it a Sell technically.
- VRCA stock price is 0.84 and Verrica Pharmaceuticals 200-day simple moving average is 5.17, creating a Sell signal.
VRCA Technical Analysis vs Fundamental Analysis
Sell
25
Verrica Pharmaceuticals (VRCA)
is a Sell
Is Verrica Pharmaceuticals a Buy or a Sell?
-
Verrica Pharmaceuticals stock is rated a Sell
The current Verrica Pharmaceuticals [VRCA] share price is $0.84. The Score for VRCA is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Verrica Pharmaceuticals Stock Info
Market Cap:
38.44M
Price in USD:
0.84
Share Volume:
342.03K
Verrica Pharmaceuticals 52-Week Range
52-Week High:
11.41
52-Week Low:
0.70
Sell
25
Verrica Pharmaceuticals (VRCA)
is a Sell
Verrica Pharmaceuticals Share Price Forecast
-
What is the Verrica Pharmaceuticals stock price today?
The Verrica Pharmaceuticals stock price is 0.84 USD today. -
Will VRCA stock go up or go down?
Verrica Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Verrica Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Verrica Pharmaceuticals is overvalued.
Is Verrica Pharmaceuticals Stock a Buy?
- Verrica Pharmaceuticals share price is 0.84 while VRCA 8-day exponential moving average is 0.97, which is a Sell signal.
- The stock price of VRCA is 0.84 while Verrica Pharmaceuticals 20-day EMA is 1.19, which makes it a Sell.
- Verrica Pharmaceuticals 50-day exponential moving average is 1.85 while VRCA share price is 0.84, making it a Sell technically.
- VRCA stock price is 0.84 and Verrica Pharmaceuticals 200-day simple moving average is 4.21, creating a Sell signal.
Fundamental Analysis of Verrica Pharmaceuticals
Is Verrica Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.25 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.73 per share.
Technical Analysis of Verrica Pharmaceuticals
Should I short Verrica Pharmaceuticals stock?
- VRCA Moving Average Covergence Divergence (MACD) indicator is -0.23, suggesting Verrica Pharmaceuticals is a Sell
- Verrica Pharmaceuticals Relative Strength Index (RSI) is 34.29, which suggest Verrica Pharmaceuticals is oversold
- The Bollinger Bands (25) for Verrica Pharmaceuticals is (0.99 - 1.61), which suggest Verrica Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Verrica Pharmaceuticals is (1.02 - 6.26), which suggest Verrica Pharmaceuticals is a Sell
* Verrica Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.